IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
na sal prep a ra tions 32%
antivaricosis/antihemorrhoidal prep a ra tions
7%
an ti his ta mines sys temic 7%
anti rheu ma tics top i cal 6%
Lead ing Dose Forms:
liq uids 35%
pow ders/gran ules 35%
tab lets 12%
gels/sols 11%
sup pos i to ries 3%
SANDOZ
Full Name: Sandoz Pharmaceuticals d.d., Rep re -
sen ta tive Of fice Lith u a nia
Street Ad dress: Seimyniskiu Str. 3A, LT-09312
Vilnius
Tel: +370 52 63 60 37
Fax: +370 52 63 60 36
Email: info.lith u a nia@gx.novartis.com
Home Page: www.sandoz.lt
De scrip tion: Rep re sen ta tive of fice. Pro moter.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, unbranded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals. 26 phar ma ceu ti -
cal employees in 2005.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 17 (2005)
Con tacts (Pharm): Mar ket Re search: Aurimas
Sumskis; Gen eral Con tact: Evaldas Navickas
Phar ma ceu ti cal Sales: US$ 9-10 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
75-80%
Prin ci pal Prod ucts:
OSPAMOX (pen i cil lin broad spec trum)
BANEOCIN (an ti bi otic/sulphonamide top i cal)
LINEX (antidiarrheal mi cro-or gan ism)
AMOKSIKLAV (pen i cil lin broad spec trum)
KETONAL (antirheumatic non-steroidal;
antirheumatic top i cal)
Ther a peu tic Range:
antibacterials sys temic 49%
an ti bi ot ics, sulphonamides and antivirals top i cal
8%
antidiarrheals, elec tro lyte re plac ers, in tes ti nal
anti-inflammatorie s 8%
dermatological antifungals 7%
anti rheu ma tics sys temic 6%
Lead ing Dose Forms:
coated tab lets 31%
cap sules 18%
vi als 11%
tab lets 11%
am poules 8%
MACEDONIA
NOVARTIS
Full Name: Novartis Pharma Ser vices AG, Rep re -
sen ta tive Of fice
Street Ad dress: 1000 Skopje, ul. Pero Nakov
b.b.
Tel: +389 2 255 0151
Fax: +389 2 255 0152
Home Page: www.mea.novartis.com
MALAYSIA
NOVARTIS
Full Name: Novartis Cor po ra tion (Ma lay sia) Sdn.
Bhd.
Postal Ad dress: PO Box 1005, 46860 Petaling
Jaya/Selangor Darul Ehs
Street Ad dress: Level 15, The Crest, 3 Two
Square, No.2, Jalan 19/1, 46300 Petaling
Jaya/Selangor Darul Ehs
Tel: +60 3 51926666
Fax: +60 3 51916514
De scrip tion: Im porter, dis trib u tor, pro moter,
sales/detailer. Im ports, dis trib utes, pro motes,
sells/de tails for other com pa nies. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded,
unbranded, pre scrip tion, non-pre scrip tion).
Established 1998.
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 14-16 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
DIOVAN (an gio ten sin-II an tag o nist plain)
GLIVEC (antineoplastic other)
VOLTAREN (antirheumatic non-steroidal)
CAFERGOT (antimigraine prep a ra tion)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 36%
© 2009 IMS Health In cor po rated or its af fil i ates Page 187